Hot Medical Stocks To Watch For 2019

Investing in the healthcare sector can sometimes feel like riding a roller coaster, but there’s little denying that the sector tends to outperform over time. Over the last 11 years, the healthcare sector has outperformed the broad-based S&P 500 in eight of those years. Furthermore, it was among the three top-performing sectors in five out of those 11 years.  

Of course, being a healthcare investor means two things: (1) You’ll need to be patient, because drug and device development takes time, and (2) you have to be picky and really do your homework, because there are a lot of companies that won’t succeed. 

With this in mind, we asked three of our Motley Fool investors to name one healthcare stock they believe could be worth buying right now. Cancer drug developer Exelixis (NASDAQ:EXEL), generic-drug manufacturer Lannett (NYSE:LCI), and medical device megacap Medtronic (NYSE:MDT) all made the cut. 

Image source: Getty Images.

Hot Medical Stocks To Watch For 2019: QuinStreet, Inc.(QNST)

Advisors’ Opinion:

  • [By Ethan Ryder]

    QuinStreet Inc (NASDAQ:QNST) has been given a consensus rating of “Buy” by the nine brokerages that are currently covering the company, MarketBeat.com reports. One research analyst has rated the stock with a hold recommendation and six have issued a buy recommendation on the company. The average 1-year price target among brokerages that have issued ratings on the stock in the last year is $17.29.

  • [By Ethan Ryder]

    QuinStreet Inc (NASDAQ:QNST) saw strong trading volume on Friday . 1,534,725 shares were traded during mid-day trading, an increase of 131% from the previous session’s volume of 665,429 shares.The stock last traded at $13.79 and had previously closed at $13.59.

  • [By Dan Caplinger]

    The mood was negative on Wall Street on Wednesday, and most major benchmarks finished in the red. Strength in the technology sector wasn’t enough to lift more cyclically focused benchmarks like the Dow Jones Industrial Average, and the combination of an attack on Saudi Arabia that sent oil prices higher and some disquieting readings on the inflation front kept investors from feeling more confident about stocks going into earnings season. In addition, some individual companies had bad news that sent their shares lower. Analogic (NASDAQ:ALOG), QuinStreet (NASDAQ:QNST), and MSC Industrial Direct (NYSE:MSM) were among the worst performers on the day. Here’s why they did so poorly.

  • [By Max Byerly]

    Schwab Charles Investment Management Inc. boosted its holdings in shares of QuinStreet Inc (NASDAQ:QNST) by 41.6% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 99,823 shares of the technology company’s stock after purchasing an additional 29,306 shares during the period. Schwab Charles Investment Management Inc. owned approximately 0.22% of QuinStreet worth $1,275,000 at the end of the most recent quarter.

  • [By Joseph Griffin]

    QuinStreet (NASDAQ:QNST) Director James R. Simons sold 229,718 shares of the company’s stock in a transaction on Thursday, May 17th. The stock was sold at an average price of $12.39, for a total transaction of $2,846,206.02. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website.

Hot Medical Stocks To Watch For 2019: Caesars Entertainment Corporation(CZR)

Advisors’ Opinion:

  • [By Shane Hupp]

    Loomis Sayles & Co. L P reduced its position in Caesars Entertainment Co. Common Stock (NASDAQ:CZR) by 8.2% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 2,472,361 shares of the company’s stock after selling 221,954 shares during the period. Loomis Sayles & Co. L P’s holdings in Caesars Entertainment Co. Common Stock were worth $27,814,000 at the end of the most recent quarter.

  • [By Jon C. Ogg]

    Some people compare the stock market to gambling and casinos. This is certainly debatable considering that millions of Americans have saved and saved and seen their assets grow in the stock market versus gambling at the casino. But what about when it comes to investing in a casino stock? That’s a fair question for the case of Caesars Entertainment Corporation (NASDAQ: CZR).

  • [By Travis Hoium]

    Gambling isn’t legal in Dubai, but that isn’t stopping Caesars Entertainment (NASDAQ:CZR) from putting its Caesars brand on a new hotel there. The company recently announced a deal with Meraas Holdings LLC to manage two luxury hotels and a beach club at Meraas’ Bluewaters Island development. 

Hot Medical Stocks To Watch For 2019: Guess?, Inc.(GES)

Advisors’ Opinion:

  • [By Shane Hupp]

    Guess?, Inc. (NYSE:GES) Director Gianluca Bolla acquired 2,832 shares of the company’s stock in a transaction that occurred on Thursday, August 30th. The shares were acquired at an average cost of $26.00 per share, with a total value of $73,632.00. Following the purchase, the director now directly owns 63,936 shares of the company’s stock, valued at approximately $1,662,336. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website.

  • [By Lisa Levin]

      

    Clearside Biomedical, Inc. (NASDAQ: CLSD) shares declined 32.19 percent to close at $9.86 on Thursday. Clearside Biomedical disclosed that its Phase 2 trial of CLS-TA met primary and secondary endpoints met in 6-month trial.
    scPharmaceuticals Inc. (NASDAQ: SCPH) shares dipped 30.1 percent to close at $9.94 on Thursday after the FDA identified deficiencies in the company’s New Drug Application for FUROSCIX. However, the FDA letter did not specify deficiencies identified and notification does not reflect final decision on information under review.
    Euroseas Ltd. (NASDAQ: ESEA) fell 24.08 percent to close at $1.86. Euroseas announced completion of the spin-off of its drybulk fleet into EuroDry Ltd.
    Golar LNG Limited (NASDAQ: GLNG) fell 25.09 percent to close at $25.98 following Q1 results.
    Oragenics, Inc. (NASDAQ: OGEN) shares dropped 25 percent to close at $1.50 on Thursday.
    Guess', Inc. (NYSE: GES) dropped 19.44 percent to close at $19.60 following Q1 results.
    Cantel Medical Corp. (NYSE: CMD) dropped 15.94 percent to close at $109.09 on Thursday following FQ3 results.
    Fusion Connect, Inc. (NASDAQ: FSNN) shares fell 15.55 percent to close at $3.91.
    Build-A-Bear Workshop, Inc. (NYSE: BBW) dropped 14.44 percent to close at $8.00 after reporting Q1 results.
    Dollar Tree, Inc. (NASDAQ: DLTR) shares declined 14.28 percent to close at $82.59 after the company reported weaker-than-expected earnings for its first quarter and lowered its FY2018 earnings guidance.
    Titan Machinery Inc. (NASDAQ: TITN) dropped 13.94 percent to close at $18.09 after reporting Q1 results.
    Co-Diagnostics, Inc. (NASDAQ: CODX) declined 13.17 percent to close at $2.90 after declining 5.65 percent on Wednesday.
    Concordia International Corp. (NASDAQ: CXRX) fell 12.89 percent to close at $0.2440 after the company announced that it would be delisted from the Nasdaq.
    Sears Holdings Corporation (NASDAQ: SHLD) slipped 12.46 percent

  • [By Stephan Byrd]

    Guess?, Inc. (NYSE:GES) saw unusually large options trading on Wednesday. Stock traders bought 2,720 put options on the company. This represents an increase of 1,093% compared to the average volume of 228 put options.

  • [By Daniel Miller]

    Shares of Guess? Inc. (NYSE:GES), an apparel retailer, were up 14% as of 11:05 a.m. EDT on Thursday after topping second-quarter earnings estimates and giving strong guidance.

Hot Medical Stocks To Watch For 2019: ImmuCell Corporation(ICCC)

Advisors’ Opinion:

  • [By Max Byerly]

    ImmuCell Co. (NASDAQ:ICCC) Director David Scott Tomsche purchased 3,000 shares of the firm’s stock in a transaction dated Thursday, August 16th. The stock was purchased at an average cost of $6.67 per share, with a total value of $20,010.00. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website.

  • [By Stephan Byrd]

    ImmuCell (NASDAQ:ICCC) released its quarterly earnings results on Monday. The biotechnology company reported ($0.04) earnings per share for the quarter, Bloomberg Earnings reports. ImmuCell had a negative net margin of 1.61% and a negative return on equity of 0.79%.

Hot Medical Stocks To Watch For 2019: Astronics Corporation(ATRO)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Astronics (NASDAQ: ATRO) and TransDigm Group (NYSE:TDG) are both aerospace companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, earnings, dividends, profitability, risk, valuation and analyst recommendations.

  • [By Stephan Byrd]

    Astronics (NASDAQ: ATRO) and Ducommun (NYSE:DCO) are both small-cap aerospace companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, valuation, analyst recommendations, profitability, risk, earnings and institutional ownership.

  • [By Ethan Ryder]

    Astronics (NASDAQ: ATRO) and Ducommun (NYSE:DCO) are both small-cap aerospace companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, risk, earnings, profitability, institutional ownership, valuation and analyst recommendations.

Hot Medical Stocks To Watch For 2019: Apple Hospitality REIT, Inc.(APLE)

Advisors’ Opinion:

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Apple Hospitality REIT (APLE)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Lee Jackson]

    Apple Hospitality REIT Inc. (NYSE: APLE) owns one of the largest portfolios of upscale, select-service hotels in the United States. Investors are paid a generous 6.67% yield. The shares traded at $17.95 early Thursday, in a 52-week range of $16.72 to $21.90. The consensus price objective is $19.25.

  • [By Max Byerly]

    Apple Hospitality REIT Inc (NYSE:APLE) insider Glade M. Knight bought 10,000 shares of Apple Hospitality REIT stock in a transaction dated Monday, August 20th. The stock was acquired at an average cost of $17.63 per share, for a total transaction of $176,300.00. Following the completion of the acquisition, the insider now directly owns 10,098,933 shares in the company, valued at $178,044,188.79. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Apple Hospitality REIT (APLE)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    Her Majesty the Queen in Right of the Province of Alberta as represented by Alberta Investment Management Corp grew its holdings in Apple Hospitality REIT Inc (NYSE:APLE) by 118.0% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 421,700 shares of the real estate investment trust’s stock after purchasing an additional 228,300 shares during the period. Her Majesty the Queen in Right of the Province of Alberta as represented by Alberta Investment Management Corp owned approximately 0.18% of Apple Hospitality REIT worth $7,409,000 as of its most recent SEC filing.

Leave a Reply

Your email address will not be published. Required fields are marked *